Current filters:  
USA
Healthcare
United States
Squire Patton Boggs LLP
In MSPA Claims 1, LLC v. Kingsway Amigo Ins. Co., the 11th Circuit was tasked with answering the question of whether 42 U.S.C. § 1395y(b)(2)(B)(vi)...
Dickinson Wright PLLC
In 2019, Michigan enacted amendments to the No-Fault Act (the "Act"), MCL 500.3101 et seq., that will affect the way health care practitioners provide services and are compensated.
McDermott Will & Emery
Digital health companies are producing innovative products at a rapidly accelerating pace and experiencing a boom in investments and demand as the regulatory environment
Buchanan Ingersoll & Rooney PC
Mike Strazzella, head of federal government relations for Buchanan Ingersoll & Rooney, talks about pricing issues in the pharmaceutical industry, the challenges he encounters
Foley & Lardner
How are businesses across the health care and life sciences spectrum collaborating to capitalize on the commercial promise of personalized medicine.
Reed Smith
We've discussed before how we expect genetic testing of plaintiffs to become routine in prescription medical product liability litigation.
McDermott Will & Emery
When it comes to market success for digital tools in the health sector, business strategy can be far more complex than in other industries.
Ogletree, Deakins, Nash, Smoak & Stewart
In August of 2019, HHS issued guidance stating that it would not enforce the April final rule until new guidance was issued.
Sheppard Mullin Richter & Hampton
As women in professional industries such as finance, healthcare, and law continue to make strides in breaking down barriers, there still remains great gender disparity when examining the leadership
Reed Smith
The Department of Health and Human Services (HHS) has modified HIPAA retail pharmacy transaction requirements to differentiate between partial fill ...
Reed Smith
The Centers for Medicare & Medicaid Services (CMS) has proposed updates to its standards for health plan issuers offering plans ...
Foley & Lardner
Federal and state legislatures have taken note of the nationwide opioid crisis and recently responded with legislative attempts to—among instituting other legal changes...
Reed Smith
CMS has put on display a proposed rule that would update Medicare Advantage (MA) and Medicare Part D prescription drug benefit policies for contract year 2021 and 2022.
Reed Smith
We would be remiss (and out of character) if we plunged into a discussion of today's case without a shout-out to "Siba,"
Squire Patton Boggs LLP
Yesterday a Sixth Circuit panel (Siler, Griffin, Kethledge) stayed pharmacies' production of national opioid dispensing data.
Sheppard Mullin Richter & Hampton
As promised, here is a summary of some key provisions in CMS' proposed rule relating to the Medicare Advantage and Part D programs for contract years 2021 and 2022.
DLA Piper
The Federal Trade Commission (FTC) issued 6(b) orders to some of the country's largest technology companies on February 11.
Buchanan Ingersoll & Rooney PC
No industry today is immune from the revolutionary impact of technology. But the healthcare sector is particularly primed to undergo significant change driven by technology in 2020.
Reed Smith
The Centers for Medicare & Medicaid Services (CMS) has released the methodology and data sources it proposes to use to determine federal payment to states that establish a Basic Health Program ...
Reed Smith
CMS is adding six types of lower limb prosthetics to the list of equipment subject to Medicare prior authorization (PA) requirements, and extending certain current PA requirements.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Upcoming Events
Tools
Font Size:
Translation
Mondaq Social Media